246 related articles for article (PubMed ID: 33327743)
1. TSP-1 (Thrombospondin-1) Deficiency Protects ApoE
Ganguly R; Khanal S; Mathias A; Gupta S; Lallo J; Sahu S; Ohanyan V; Patel A; Storm K; Datta S; Raman P
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e112-e127. PubMed ID: 33327743
[TBL] [Abstract][Full Text] [Related]
2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
3. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
4. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
[TBL] [Abstract][Full Text] [Related]
5. IL-1β Inhibition Partially Negates the Beneficial Effects of Diet-Induced Atherosclerosis Regression in Mice.
Karnewar S; Karnewar V; Deaton RA; Shankman LS; Benavente ED; Williams CM; Bradley X; Alencar GF; Bulut GB; Kirmani S; Baylis RA; Zunder ER; den Ruijter HM; Pasterkamp G; Owens GK
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1379-1392. PubMed ID: 38695167
[TBL] [Abstract][Full Text] [Related]
6. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein-D deficiency suppresses systemic inflammation and reduces atherosclerosis in ApoE knockout mice.
Hirano Y; Choi A; Tsuruta M; Jaw JE; Oh Y; Ngan D; Moritani K; Chen YR; Tam S; Li Y; Vasilescu DM; Hogg JC; Francis G; Bernatchez P; Man SP; Sin DD
Cardiovasc Res; 2017 Aug; 113(10):1208-1218. PubMed ID: 28472244
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
9. Differential Roles of Endothelial Cell-Derived and Smooth Muscle Cell-Derived Fibronectin Containing Extra Domain A in Early and Late Atherosclerosis.
Doddapattar P; Dev R; Jain M; Dhanesha N; Chauhan AK
Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1738-1747. PubMed ID: 32434411
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
[TBL] [Abstract][Full Text] [Related]
11. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
12. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
13. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
McGraw AP; Bagley J; Chen WS; Galayda C; Nickerson H; Armani A; Caprio M; Carmeliet P; Jaffe IZ
J Am Heart Assoc; 2013 Feb; 2(1):e000018. PubMed ID: 23525413
[TBL] [Abstract][Full Text] [Related]
15. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
[TBL] [Abstract][Full Text] [Related]
16. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
17. P2Y
Niu X; Pi SL; Baral S; Xia YP; He QW; Li YN; Jin HJ; Li M; Wang MD; Mao L; Hu B
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):515-524. PubMed ID: 28062501
[TBL] [Abstract][Full Text] [Related]
18. β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice.
Murugesan V; Degerman E; Holmen-Pålbrink AK; Duner P; Knutsson A; Hultgårdh-Nilsson A; Rauch U
J Vasc Res; 2017; 54(4):235-245. PubMed ID: 28768281
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific differences in atherosclerosis, thrombospondin-1, and smooth muscle cell differentiation in metabolic syndrome versus non-metabolic syndrome mice.
Gupta S; Khanal S; Bhavnani N; Mathias A; Lallo J; Kiriakou A; Ferrell J; Raman P
Front Cardiovasc Med; 2022; 9():1020006. PubMed ID: 36505365
[TBL] [Abstract][Full Text] [Related]
20. Intermedin
Ren JL; Hou YL; Ni XQ; Zhu Q; Chen Y; Zhang LS; Liu X; Xue CD; Wu N; Yu YR; Tang CS; Ning ZP; Chai SB; Qi YF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):251-264. PubMed ID: 31698947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
